欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号PT/H/0867/003
药品名称Beta-histina Aurobindo
活性成分
    • betahistine hydrochloride 24.0 mg
剂型Tablet
上市许可持有人Aurobindo Pharma (Portugal), Unipessoal Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Bulgaria (BG)
      Betahistine Aurobindo
    • Netherlands (NL)
    • France (FR)
    • Italy (IT)
    • Czechia (CZ)
      Betahistin Aurobindo 24 mg tablety
    • Romania (RO)
      Betahistina diclorhidrat Aurobindo 24 mg comprimate
    • Malta (MT)
      Betahistine 24 mg tablets
许可日期2014/07/10
最近更新日期2023/05/23
药物ATC编码
    • N07CA01 betahistine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase